Schinzari, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1211
EU - Europa 1126
AS - Asia 250
OC - Oceania 11
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2607
Nazione #
US - Stati Uniti d'America 1204
DE - Germania 403
SE - Svezia 371
CN - Cina 157
IT - Italia 117
UA - Ucraina 67
PL - Polonia 52
IN - India 47
FR - Francia 41
GB - Regno Unito 28
TR - Turchia 19
FI - Finlandia 16
IR - Iran 16
AU - Australia 11
BE - Belgio 10
RO - Romania 10
CA - Canada 6
PE - Perù 4
EU - Europa 3
GR - Grecia 3
JP - Giappone 3
NL - Olanda 3
CY - Cipro 2
ES - Italia 2
PK - Pakistan 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
HK - Hong Kong 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 2607
Città #
Chandler 350
Wilmington 65
San Mateo 60
Fairfield 56
Ann Arbor 55
Ashburn 55
Warsaw 52
Princeton 45
Jacksonville 42
Nanjing 42
Boston 38
Dearborn 35
Cattolica 33
Redwood City 26
Nürnberg 25
Woodbridge 25
Cambridge 24
Redmond 24
Bremen 20
Houston 20
Seattle 20
Izmir 17
Nanchang 17
Beijing 16
Falls Church 14
Hebei 12
Lawrence 12
Rome 12
Shanghai 12
Augusta 11
Norwalk 11
Brussels 10
Leawood 10
Changsha 8
Kish 7
Mountain View 7
Jiaxing 6
Kunming 6
Milan 6
Shenyang 6
Andover 5
Fremont 5
San Diego 5
Boardman 4
Chicago 4
Hangzhou 4
Lima 4
Munich 4
Sydney 4
University Park 4
Winston Salem 4
Ardea 3
Berlin 3
Detroit 3
Hefei 3
Kashan 3
Lanzhou 3
Los Angeles 3
Northbrook 3
Tianjin 3
Acquaviva delle Fonti 2
Burlington 2
Changchun 2
Clearwater 2
Dong Ket 2
Duncan 2
Garden City 2
Gunzenhausen 2
Helsinki 2
Jinan 2
Lancaster 2
Las Vegas 2
Mumbai 2
Nicosia 2
Phoenix 2
Sacramento 2
Taiyuan 2
Thessaloníki 2
Tokyo 2
Winnipeg 2
Xian 2
Zhengzhou 2
Amsterdam 1
Ardabil 1
Arzano 1
Atri 1
Caltanissetta 1
Cerveteri 1
Cluj-Napoca 1
Costa Mesa 1
Cupertino 1
Dallas 1
Foggia 1
Gatineau 1
Gavirate 1
Groningen 1
Guangzhou 1
Gurgaon 1
Hyderabad 1
Islamabad 1
Totale 1448
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 234
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 160
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 111
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 108
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 100
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 88
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 86
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 85
Are TKIs favourable for the elderly with non-small-cell lung cancer? 81
null 75
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 64
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 63
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 61
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 59
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 59
null 49
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 46
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 45
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 44
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 43
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 41
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 41
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 39
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 39
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 38
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 35
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 35
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 34
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 34
Skin cancer triage and management during COVID-19 pandemic. 33
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 32
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 32
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 31
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 31
Methylation study of the Paris system for reporting urinary (TPS) categories 31
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 30
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 30
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 29
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 28
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 28
Efficacy of immune checkpoint inhibitors in different types of melanoma 26
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 26
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 25
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 24
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 23
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 22
Biomarkers of response to advanced prostate cancer therapy 22
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 21
Targeted therapy in advanced gastric carcinoma: The future is beginning 19
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 19
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 19
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 17
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 16
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 15
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 15
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 14
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 13
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 10
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 6
Totale 2684
Categoria #
all - tutte 5160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201858 0000 07 211 141509
2018/2019179 1042 2529 335 10263113
2019/2020503 91302658 4235 7313 24227019
2020/2021245 1019815 309 339 3128503
2021/2022630 58181599 3914 1382 334395121
2022/2023754 184183104232 510 00 0000
Totale 2684